EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Research Progress on the Immunological Correlation Between Papillary Thyroid Carcinoma and Hashimoto’s Thyroiditis

Digui Fang, Limei Zhou, Biao Zheng iD

Journal of Immunology Research · 2025-01 · 2025 (1)

DOI: 10.1155/jimr/7192808 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Immunology Research, online erschienen am 23.04.2025. Verfasst von Digui Fang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid and Parathyroid Surgery, The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan, China. Hauptthemen laut MEDLINE: Hashimoto Disease, Thyroid Cancer, Papillary, Thyroid Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Guangdong Medical College.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, a growing body of evidence has suggested a correlation between Hashimoto’s thyroiditis (HT) and the onset and progression of papillary thyroid carcinoma (PTC). However, the mechanism underlying the relationship between HT and PTC remains incompletely understood. This review discusses the literature on the correlation between PTC and HT and summarizes the research concerning the immunological interplay between these two conditions. It also delves into tumor‐associated cells (such as CD8+ T cells), tumor‐associated macrophages (TAMs), regulatory T cells (Tregs), and cancer‐associated fibroblasts (CAFs), alongside other tumor‐associated factors, including interleukins (ILs), interferon‐gamma (IFN‐ γ ), tumor necrosis factor‐alpha (TNF‐ α ), cyclooxygenase‐2 (COX‐2), inducible nitric oxide synthase (iNOS), and hypoxia‐inducible factor‐1 (HIF‐1), highlighting their roles in the interaction between PTC and HT. We also explore the strategic direction of immunotherapy in thyroid malignancies, particularly PTC with HT, and propose novel targeted immunotherapies for advanced thyroid cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hashimoto DiseaseThyroid Cancer, PapillaryThyroid NeoplasmsHumansTumor MicroenvironmentAnimalsTumor-Associated MacrophagesCytokinesT-Lymphocytes, RegulatoryImmunotherapyDisease Susceptibility

Substanzen

Cytokines

Autor:innen und Institutionen

  • Department of Thyroid and Parathyroid Surgery, The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan, China.

ORCID-Profile: Biao Zheng

Förderung

  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Guangdong Medical College

Zitieren

APA

Fang, D., Zhou, L., & Zheng, B. (2025). Research Progress on the Immunological Correlation Between Papillary Thyroid Carcinoma and Hashimoto’s Thyroiditis. Journal of Immunology Research, 2025(1). https://doi.org/10.1155/jimr/7192808

Vancouver

Fang D, Zhou L, Zheng B. Research Progress on the Immunological Correlation Between Papillary Thyroid Carcinoma and Hashimoto’s Thyroiditis. Journal of Immunology Research. 2025;2025(1). doi:10.1155/jimr/7192808

BibTeX
@article{Fang2025,
  author = {Fang, Digui and Zhou, Limei and Zheng, Biao},
  title = {Research Progress on the Immunological Correlation Between Papillary Thyroid Carcinoma and Hashimoto’s Thyroiditis},
  journal = {Journal of Immunology Research},
  year = {2025},
  volume = {2025},
  number = {1},
  doi = {10.1155/jimr/7192808}
}
Kostenlos starten →